- Senate Lays Groundwork for 340B Reporting Legislation Modern Healthcare by Susannah Luthi — Senators on Thursday signaled their chamber will join the U.S. House of Representatives to push hospitals to report where they direct their 340B drug discounts, wading into the fierce lobbying battle between Big Pharma and hospitals that has been waging for months. In an often-contentious Senate Health, Education, Labor & Pensions Committee hearing Thursday, Chair Lamar Alexander (R-Tenn.) made it clear he wants to know where hospitals and clinics are applying the discounts they get from drugmakers, how much of the discounts go directly to patients and which kinds of programs the providers are funding for patients with the money that isn't directly passed on. "That could lead to question of whether we could restrict [where the money goes]," Alexander said. "But one way to avoid restrictions is to help us know better what the money is going for."